Mr. Wehrly is a seasoned leader in the medical device and biotech industries that consistently delivers top-line growth and operational efficiencies. Prior to joining Vivex Biologics as CEO, Mr. Wehrly was the former CEO and Chairman of the Board of Synaptive Medical, a privately held Toronto-based company that focused on uniting highly innovative technology with the medical device industry for neuro-cranial and spinal markets. Mr. Wehrly was previously Group President, heading the global business in Western Europe, Japan, Canada, Australia and New Zealand for Covidien. He earned his BS in Management from Ball State University and has completed several advanced management programs including a program at the IMD International School of Management in Lausanne, Switzerland.
.svg)
